Target intelligence / Profile preview

Ubiquitin specific peptidase 17-like family member 2 (USP17L2)

Target
USP17L2
Molecular classification
Enzyme, Deubiquitinating enzyme, Ubiquitin-specific protease (USP) family, Peptidase C19 family
01

Overview

Ubiquitin specific peptidase 17-like family member 2 (USP17L2, commonly called DUB3) is a cysteine-type deubiquitinating enzyme in the peptidase C19 family. It removes ubiquitin from specific protein substrates, thereby regulating multiple cellular processes. Key functions include controlling cell proliferation by stabilizing critical cell cycle proteins (such as CDC25A) and modulating localization and activation of small GTPases (such as NRAS and HRAS) via the deubiquitination of RCE1. USP17L2 also regulates cell migration, apoptosis, and the innate immune response by acting on proteins such as SUDS3, and cytoplasmic immune receptors like RIG-I and IFIH1. Dysregulation of USP17L2 has been linked to cancer and other proliferative diseases. The enzyme is not currently directly targeted by approved drugs, but its biological roles make it an area of active research as a potential therapeutic target, especially in oncology.

Other names
DUB3USP17USP17HUSP17IUSP17JUSP17KUSP17LUSP17MDeubiquitinating enzyme 3Deubiquitinating protein 3Ubiquitin carboxyl-terminal hydrolase 17Ubiquitin carboxyl-terminal hydrolase 17-like protein 2Ubiquitin thioesterase 17-like protein 2Ubiquitin-specific-processing protease 17-like protein 2Deubiquitinating enzyme 17-like protein 2Ubiquitin specific peptidase 17-like 2
02

Mechanism of action

Inhibition of deubiquitinase activity (theoretically, for any substances or tool compounds developed in research may act by inhibiting USP17L2’s cysteine-type deubiquitinase activity, leading to increased ubiquitination and degradation of its substrates)

03

Biological functions

Protein deubiquitinationRegulation of cell proliferationCell cycle regulation (G1/S, G2/M progression)Apoptosis regulationRegulation of cell migrationRegulation of innate immune response (response to viral infection)
04

Disease associations

CancerMachado-Joseph diseasePotential role in inflammatory processes
05

Safety considerations

Potential for effects on cell proliferation, cell cycle, and apoptosis—raising risks of toxicity in proliferative tissues if inhibited broadlyInvolvement in immune signaling pathways may present risk for immunosuppression or inappropriate immune activation if targeted

Beyond the preview

Go deeper on Ubiquitin specific peptidase 17-like family member 2 (USP17L2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin specific peptidase 17-like family member 2 (USP17L2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call